« Health ministry probes Diovan skin disruption reports | Main | FDA warns on Daiichi Sankyo blood pressure drugs »

July 31, 2013

Novartis Gilenya Patient Diagnosed With Rare Infection

Quoted from http://www.bloomberg.com/news/2013-07-30/novartis-gilenya-patient-diagnosed-with-rare-infection.html

Novartis Gilenya Patient Diagnosed With Rare Infection

By Phil Serafino - Jul 30, 2013 11:50 AM ET

A patient taking Novartis AG (NOVN)’s Gilenya multiple sclerosis pill contracted a potentially deadly brain infection, adding to concern that the medicine may lose ground to a competing product. 
 

Unlike a previous case, the patient hadn’t taken Biogen Idec Inc. (BIIB)’s Tysabri injection, an MS drug that increases the risk of the viral infection, known as progressive multifocal leukoencephalopathy, Novartis said in an e-mail today.

[Article continues at original source]

Posted at 09:44 AM in Gilenya |

Tags: drug injury, Gilenya, multiple sclerosis pill, Novartis AG, PML, progressive multifocal leukoencephalopathy, side effects, viral infection

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required